TrianglePUBLICATIONS · 16638934
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2006 Sep 1
- First author
- Wassmann B
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wassmann B
- type
- Author
- name
- Pfeifer H
- type
- Author
- name
- Goekbuget N
- type
- Author
- name
- Beelen DW
- type
- Author
- name
- Beck J
- type
- Author
- name
- Stelljes M
- type
- Author
- name
- Bornhäuser M
- type
- Author
- name
- Reichle A
- type
- Author
- name
- Perz J
- type
- Author
- name
- Haas R
- type
- Author
- name
- Ganser A
- type
- Author
- name
- Schmid M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wassmann B
- type
- Author
- name
- Pfeifer H
- type
- Author
- name
- Goekbuget N
- type
- Author
- name
- Beelen DW
- type
- Author
- name
- Beck J
- type
- Author
- name
- Stelljes M
- type
- Author
- name
- Bornhäuser M
- type
- Author
- name
- Reichle A
- type
- Author
- name
- Perz J
- type
- Author
- name
- Haas R
- type
- Author
- name
- Ganser A
- type
- Author
- name
- Schmid M
- type
- Author
- bibliography ids
- nci-bib-f3f82161c56b50d59165df80
- book metadata
- content sha256
- 9635c0cdcfcc21350e287eb5ee4c3dab9650b6b6beeb48475a942a8d7a961087
- document type
- citation
- dois
- 10.1182/blood-2005-11-4386
- electronic publication date
- display
- 2006 Apr 25
- precision
- day
- year
- 2006
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16638934
- immutable id
- pubmed:16638934@9635c0cdcfcc21350e287eb5ee4c3dab9650b6b6beeb48475a942a8d7a961087
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 5
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1469-77
- volume
- 108
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16638934
- provenance
- batch id
- 19fb2de9a00882c94e86
- provider
- NCBI PubMed ESummary
- record sha256
- 13da0048c256f3a2799147b7d51ab6b9bd770cb860b08e2ae58a388d8fd0d601
- response sha256
- 4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
- retrieved at
- 2026-09-09T23:46:06.810486+00:00
- publication date
- display
- 2006 Sep 1
- precision
- day
- year
- 2006
- publication types
- Comparative Study
- Controlled Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Preserved source evidence · Not medical advice